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Abstract
Background: Human peripheral blood is a promising material for biomedical research. However, various kinds of biological
and technological factors result in a large degree of variation in blood gene expression profiles.
Methodology/Principal Findings: Human peripheral blood samples were drawn from healthy volunteers and analysed
using the Human Genome U133Plus2 Microarray. We applied a novel approach using the Principle Component Analysis and
Eigen-R
2 methods to dissect the overall variation of blood gene expression profiles with respect to the interested biological
and technological factors. The results indicated that the predominating sources of the variation could be traced to the
individual heterogeneity of the relative proportions of different blood cell types (leukocyte subsets and erythrocytes). The
physiological factors like age, gender and BMI were demonstrated to be associated with 5.3% to 9.2% of the total variation
in the blood gene expression profiles. We investigated the gene expression profiles of samples from the same donors but
with different levels of RNA quality. Although the proportion of variation associated to the RNA Integrity Number was mild
(2.1%), the significant impact of RNA quality on the expression of individual genes was observed.
Conclusions: By characterizing the major sources of variation in blood gene expression profiles, such variability can be
minimized by modifications to study designs. Increasing sample size, balancing confounding factors between study groups,
using rigorous selection criteria for sample quality, and well controlled experimental processes will significantly improve the
accuracy and reproducibility of blood transcriptome study.
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Introduction
Peripheral blood is a very promising material for biomedical
research due to its critical role in immune responses and
metabolism. The ease and minimal invasiveness with which it
can be collected have also made peripheral blood attractive for
clinical use. Over the last decade, advances in microarray have
offered the opportunity to study the expression of thousands of
genes simultaneously in a biological system. The microarray-based
transcriptome analyse of peripheral blood may provide new
insights into the variations in global gene expression specifically
associated with physiological and pathological events. Numerous
studies have addressed the use of gene expression profiling of
peripheral blood from patients with malignancies, infectious
diseases, autoimmunity and cardiovascular diseases [1,2].
Before the blood transcriptomic biomarkers can be used for
clinical purposes, it is essential to understand the underlying
factors that contribute to the sources of variability in blood gene
expression profiles. Previous studies have investigated the blood
gene expression profiles of normal individuals [3]. Those studies
used either whole blood or peripheral blood mononuclear cells.
Gene expression profiles were found varying greatly among the
different blood cell types [4–6]. The results demonstrated the
significant contributions of genetic and physiological factors, as
well as varying proporations of different cellsubsets, in
determining the overall gene expression profiles of human
blood [7–9]. Yet other research also provided evidences that
gene expression profiles of normal individuals can be remark-
ably stable over time [10,11]. Several studies reported an excess
of hemoglobin mRNA present in total RNA extracted from
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26905whole blood resulting in high noise and reduced sensitivity in
transcriptome analysis [12,13]. The usefulness of available
methods to minimize excess hemoglobin mRNA was then
evaluated [14]. Furthermore, technological factors such as
sample collection, transportation and storage conditions, as well
as RNA isolation and amplification techniques, in addition to
biological factors, can have a significant impact on the blood
gene expression profiles [15–20].
In the study described here, we used the PAXgene
TM Blood
RNA System and GeneChipH U133Plus2 Microarray to analyze
gene expression profiles in peripheral blood from healthy Chinese
volunteers. For each donor, the physiological variables and blood
cell counts were measured. The blood gene expression profiles
were investigated for possible interference of age, gender, body
mass index (BMI), sample RNA quality, as well as the presence of
varying proportions of different blood cell types.
Methods
Human Blood Sample Collection
For gene expression profiling, 2.5 ml of peripheral blood were
drawn from each volunteer by PAXgene
TM Blood RNA tubes
(PreAnalytix, Hilden, Germany). Another 2 ml of blood were
collected for Complete Blood Count analysis. The test was
performed by standard procedures at the Fudan University
Shanghai Cancer Center Clinical Laboratory. The measures
included white blood cell counts (leukocyte counts, relative counts
for neutrophils, lymphocytes and monocytes), red blood cell counts
(erythrocyte counts, hemoglobin amount, and relative reticulocyte
count), as well as platelet counts. This study was carried out at the
Fudan University Shanghai Cancer Center and was approved by
the Ethical Committee of Fudan University Shanghai Cancer
Center for Clinical Research. The written informed consents were
obtained from all participants.
RNA Isolation and Preparation
Once blood samples were drawn into the PAXgene
TM Blood
RNA tubes by standard phlebotomy procedure, the samples were
inverted ten times, maintained at room temperature for 2 hours,
frozen at 220uC overnight and then moved to 280uC for storage
until further use. Frozen blood samples were thawed at room
temperature for 3 hours, followed by total RNA extraction with
the PAXgene
TM Blood RNA kit according to the manufacturer’s
instruction. The intact total RNA of each participant was
separated into three tubes (Figure 1). While the 1
st tube was kept
intact, the 2
nd and 3
rd tubes were heated at 70uC for 10 and 20
minutes, respectively. The quantity of the total RNA was
measured by a spectrophotometer at an optical density (OD) of
260 nm. Total RNA purity was assessed by the A260/A280 ratio.
RNA Integrity Number (RIN) was determined using RNA 6000
Nano Chips and the Agilent 2100 Bioanalyzer (Agilent Technol-
ogies, Palo Alto, CA, U.S.A.).
Microarray Experiments
We reversely transcribed 50 ng of total RNA and linearly
amplified single-stranded cDNA using Ribo-SPIA
TM technology
with the WT-Ovation
TM RNA Amplification System (NuGEN
Technologies Inc., San Carlos, CA, USA) according to the
manufacturer’s standard protocol. The reaction products were
purified with a QIAquick PCR purification kit (QIAGEN
GmbH, Hilden, Germany). We subsequently fragmented 2 mg
of amplified and purified cDNA with RQ1 RNase-Free DNase
(Promega Corp., Fitchburg, WI, USA) and labelled the
fragments with biotinylated deoxynucleoside triphosphates
using terminal transferase (Roche Diagnostics Corp., Indianap-
olis, IN, USA) and GeneChipH DNA Labeling Reagent
(Affymetrix Inc., Santa Clara, CA, USA). The labelled cDNA
was then hybridized onto a GeneChipH U133Plus2 Array
(Affymetrix) in a Hybridization Oven 640 (Agilent Technolo-
gies) at 60 rotations per minute and 50uC for 18 hours. After
hybridization, the arrays were washed and stained according to
Affymetrix protocol EukGE-WS2v4 using a GeneChipH Fluidics
Station 450 (Affymetrix). The arrays were scanned with a
GeneChipH Scanner 3000 (Affymetrix). All reactions and array
hybridizations were carried out by the same technician to
minimize the technical variation.
Statistical Analysis
Statistical analysis was performed using R software and
packages from the Bioconductor microarray analysis environ-
ment [21,22], adapted to our needs. Gene expression profiles
were quantified using the Robust Multi-array Average (RMA)
method [23–25] implemented in the ‘‘Simpleaffy’’ package [26].
The GeneChipH U133plus2.0 Array contains 54,000 probesets
for the interrogation of 38,500 human genes. Very often,
multiple probesets are targeting to the unique gene. It is also
found that several probesets were poorly annotated without any
target gene. To reduce the noise and redundancy, we applied a
bioinformatics-based filter using the information of Entrez Gene
Database. For multiple probese t sm a p p i n gt ot h es a m eE n t r e z
Gene ID, only the probeset showing the largest Inter Quantile
Range (IQR) were retained and the others were removed. The
probesets without Entrez Gene ID annotation were also
removed. After bioinformatics-based filtering, the expression
profiles of 9859 genes in 24 samples were retained for the
downstream analysis.
Let Y be a m|nmatrix, where the rows of Y are the genes
(m=9859) and the columns of Y are the samples (n=24).
Although with the bioinformatics filtering, the difficulty
remained in the fact that the number of genes was still much
larger than the number of samples. Thus, we performed
Principle Component Analysis (PCA) to reduce the dimension-
a l i t yo fg e n ee x p r e s s i o nd a t a .I nP C A ,s i n g u l a rv a l u e
decomposition was applied to the mean centered data matrix
and decomposed Y into the following:
Y~UDVT
where the matrices U and Vwere column orthogonal, so that
UTU~VTV~I and D was a diagonal matrix. The columns of
Vwere the right eigenvectors and also called principle components
(PCs). We were particularly interested in the PCs because these
represented the aggregated trends in the gene expression profiles.
Specifically, the first PC was the linear combination of the gene
expression profiles that explained the most variation in the data.
The second PC was the linear combination of the gene expression
profiles that explained the most variation in the data once the first
PC had been removed, and so on. The proportion of total
variation captured by the i-th PC was given by:
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where i=1,2,..,n; di was the eigenvalue of the i-th eigenvector,
which was obtained from the i-th diagonal entry of D. Afterwards,
a PCA extended method, called ‘‘Eigen-R
2’’ [27], was used to
precisely determine the proportion of variation explained by the
predefined biological and technological variables X based on the
PCA transformed data. Let pi be the i-th PC and let ^ p pi be the fitted
values when modelling pi in terms of the predefined variable X.
For each of PCs, the proportion of variation in pi that is explained
by X was calculated by:
R2
^ p pi~
^ s s2
^ p pi
^ s s2
pi
~
Pn
j~1 (^ p pij{  ^ p p ^ p pi)
2
Pn
j~1 (pij{  p pi)
2
where   ^ p p ^ p pi was the mean of ^ p pi and   p pi was the mean of pi. Since pi
of the total variation in the data is explained by pi, R2
^ p pi should be
weighted by pi. Additionally, given each pair of PCs is
uncorrelated, the variation explained by X in pi is orthogonal
to the variation explained by X in pj where j=i. Therefore,
the proportion of total variation explained by X was estimated
by:
Figure 1. The study design for evaluating the impact of RNA quality on the blood gene expression profiles. From each healthy
volunteer, 2.5 ml of peripheral blood was collected using a PAXgene
TM Blood RNA tube. The extracted total RNA from each individual was aliquoted
into three tubes. The 1
st tube was kept intact, while the 2
nd and 3
rd tubes were heated at 70uC for 10 and 20 minutes, respectively. According to the
RNAs processing, microarray experiments were then performed in the sequential series: Series_1, Series_2 and Series_3. The RIN value was measured
and used as the technical variable for evaluating the impact of RNA quality on the blood gene expression profiles.
doi:10.1371/journal.pone.0026905.g001
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Given the small cohort of present study, we further adjusted the
R
2 calculation to accommodate small sample sizes by:
adjusted{R2~1{
(1{R2)|(n{d0)
(n{d)
where d0 and d were the degrees of freedom spent in fitting the
null model and the target model, respectively. By default, the null
model was a model with only intercept (d0 =1). The adjusted
estimator had been shown to be a unbiased estimator of the true
value [28].
The gene-wise linear analysis was performed using the lmFit()
function from the ‘‘Limma’’ package [29], adjusted for multiple
testing with False Discovery Rate (FDR) [30]. For each gene, a
linear model was fitted over the series of arrays with the log2-
transformed gene expression intensity as the dependent variable
and the biological and technological factors as the independent
variables. The functional annotation enrichment analysis for gene
ontology and pathways were performed by the DAVID Bioinfor-
matics Resource (http://david.abcc.ncifcrf.gov) with default
parameters [31].
The microarray dataset discussed in this study were MIAME
compliant [32]. The raw data had been deposited in ArrayExpress
Database [33] and were accessible through the accession number:
E-MEXP-2917.
Using the Independent Dataset for in silico Validations
Given the small sample size in the present study, we further used
an independent, previously published blood gene expression
dataset to verify our findings [10]. The Karlovich et al. study
employed the same methodologies for the sample collection
(PAXgene
TM Blood RNA System) and gene expression profiling
(HG-U133Plus2 Microarray), hence we considered the dataset an
appropriate material to perform the in silico validation. From the
Karlovich et al. dataset, we selected a total of 100 arrays with blood
samples drawn from 20 (11 female and 9 male) healthy volunteers
at five time points (Starting day, Day 14, Day28, Day90 and Day
180). All volunteers were Caucasians and lived in eastern France.
The volunteers ranged in age from 23 to 64 yr (mean 6
SD=46615). The age distribution was well balanced between
men and women. The raw data were downloaded from NCBI’s
Gene Expression Omnibus [34] with the accession number:
GSE16028.
Gene Expression Analysis by Real-time PCR
For each sample, 0.2 mg of total RNA was reverse-transcribed
into cDNA using the Prime Script
TM reverse transcriptase (TaKaRa,
Dalian, China). Real-time PCR analysis was performed by the
LightCyclerH 480 system (Roche Diagnostics, Mannheim, Ger-
many) in 96-well plates using the SYBR Premix Ex Taq
TM
(TaKaRa, Dalian, China) according to the manufacturer’s
instructions. Primer designs were provided in the Table S1. ACTB
(b-actin) was used as an internal control. The relative quantifica-
tion of mRNA expression was calculated as a ratio of target gene
to ACTB. The correlations of real-time PCR data with microarray
data and predefined variables were assessed by the Spearman’s
Rank Correlation Test.
Results
Sample Characteristics and Variable Definition
Peripheral blood samples were taken from 8 (4 female and 4
male) apparently healthy volunteers. All volunteers were Chinese,
not on medication and non-fasted. The volunteers ranged in age
from 22 to 35 yr (mean 6 SD=27.164.1). The age distribution
was balanced between men and women. The volunteers’ height
and weight were measured and converted into BMI. The BMI
ranged from 17.6 to 29.4 (mean 6 SD=21.363.7). For each
volunteer, the blood cell counts including leukocyte count,
lymphocyte%, monocyte%, neutrophil%, erythrocyte count,
hemoglobin amount, reticulocyte% and platelet count were
measured.
We performed Spearman’s Rank Correlation Test to explore
the correlationship between age, gender, BMI and blood cell
counts (Figure 2). Given that lymphocytes and neutrophils
together making up 80–95% of total leukocytes, not surprisingly,
the lymphocyte% and neutrophil% was inversely correlated with
each other (r=20.95, P-value,0.001). The erythrocyte count,
hemoglobin amount, monocyte% as well as BMI were observed
significantly correlated with the gender factor (P-value,0.001).
The reticulocyte% and platelet count were also found to be
correlated with each other (r=0.69, P-value,0.001). The age
variable was not apparently correlated with any other variable.
Furthermore, the RIN value was measured to assess the RNA
integrity on a scale from 0 (low integrity) to 10 (high integrity) [35].
Afterward, it was used to investigate the effect of RNA quality on
the blood gene expression profiles. All the sample characteristics
on the basis of demography, blood cell counts and RNA quality
were given in the Table 1.
Investigation of Variation in Blood Gene Expression
Profiles
Our blood gene expression dataset contained 9859 genes and
24 samples. The goal is to dissect the variation of thousands of
gene expression profiles and characterise the underlying factors
that contributed to the data variability. For this purpose,
sophisticated data analysis methods were required. PCA is a
widely used unsupervised linear technique for dimensionality
reduction. The central idea behind PCA is to transform the
original dataset consisting of a larger number of interrelated
variables to a new set of uncorrelated principal components
(PCs), while retaining as much as possible the variation present in
the original data set [36]. Therefore, we used PCA to decompose
the overall data variation into a set of PCs (Table S2). It was
noteworthy that the Top-10 PCs explained 85% of the total
variation, suggesting that the gene expression profiles might be
affected by only few but significant factors. To explore and
visualise the major sources of variation, samples were displayed in
a 3-dimensional space consisting of the Top-3 PCs which
explained 28.2%, 17.0% and 10.2% of the total variation,
respectively. In the Figure 3, the spatial distance between the
samples actually reflected their approximate degree of transcrip-
tional similarity. Interestingly, the samples from each individual
across experimental series were in close proximity to one another
on the plane of PC1 and PC2, while male and female groups
were separated in the direction of PC3. All of PCs transformed
from original gene expression data were retained to avoid any
information loss. Furthermore, a PCA extended method, called
‘‘Eigen-R
2’’, was used to precisely determine the proportion of
variation related to the predefined biological and technological
factors based on the PCA transformed data (Table 2).
Gene Expression Profiling of Human Whole Blood
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26905Figure 2. Heatmap of correlationship between demography variables and blood cell count measures. The Spearman’s Rank Correlation
Test was performed to assess the correlationship between age, gender, BMI and blood cell counts. The absolute values of correlation coefficients
were represented as the heatmap with red colour indicating high correlations and green colour indicating low correlations between the variables.
doi:10.1371/journal.pone.0026905.g002
Table 1. Sample information on the basis of demography, blood cell counts and RNA quality.
Variable Men Women Total
Mean±SD Study Range Mean±SD Study Range Mean±SD Study Range
Age 28.364.6 25–35 26.063.9 22–31 27.164.1 22–35
BMI 23.664.0 20.2–29.4 19.061.1 17.6–20.2 21.363.7 17.6–29.4
Leukocyte (10ˆ9/l) 6.862.9 3.6–10.6 5.660.5 5.0–6.1 6.262.0 3.6–10.6
Lymphocyte% 28.969.2 20.0–40.8 32.664.3 28.5–38.6 30.767.0 20.0–40.8
Monocyte% 7.060.9 6.8–7.9 5.761.1 4.7–7.2 6.461.2 4.7–7.9
Neutrophil% 61.269.7 48.4–69.4 59.865.0 52.4–62.8 60.567.2 48.4–69.4
Erythrocyte (10ˆ12/l) 5.560.4 4.9–5.9 4.360.3 4.1–4.7 4.960.7 4.1–5.9
Hemoglobin (gm/dL) 162.5611.1 147–171 129.868.5 122–139 146.1619.8 122–171
Reticulocyte% 0.560.2 0.3–0.7 0.460.4 0.2–1.0 0.560.3 0.2–1.0
Platelet(10ˆ9/l) 246.0628.9 206–275 247.5656.1 190–322 246.8641.3 190–322
RIN Value 7.761.2 6.3–9.2 7.861.0 5.8–9.2 7.761.1 5.8–9.2
doi:10.1371/journal.pone.0026905.t001
Gene Expression Profiling of Human Whole Blood
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of RNA Degradation on Blood Gene Expression Profiles
It is widely believed that the highest quality RNA should be
used for gene expression analyses. However, in some cases, such as
human autopsy samples or paraffin embedded tissues, high quality
RNA samples may not be available. Previous studies had
investigated how the RNA quality might affect the gene expression
profiles in the tissue samples [37,38], remarkably little is know for
the situation in blood. In this work, with a specific study design, we
intended to explore the possible effect of sample quality on the
blood gene expression profiles (Figure 1). The extracted total RNA
from each individual was aliquoted into three tubes. The 1
st tube
was kept intact, while the 2
nd and 3
rd tubes were heated at 70uC
for 10 and 20 minutes, respectively. According to the RNAs
preparation, microarray experiments were then performed in the
sequential series: Series_1, Series_2 and Series_3. The average
RIN value for Series_1, Series_2 and Series_3 were 8.9, 7.7 and
6.5, respectively. The distributions of RIN value between series
were significantly different (P-value,0.001).
The RIN variable was shown to be associated with 2.1% of the
total variation in blood gene expression data. The effect of RNA
quality on the expression of individual genes was estimated
through the gene-wise linear analysis at FDR ,0.01. We identified
28 genes which the expression profiles were significantly associated
with the RIN variable. The list of genes was submitted to the
DAVID Bioinformatics Resource for functional enrichment
analysis. The overview of variable-associated-gene list and
enriched functional annotation terms were provided in the Table
S3. The genes involved in ‘‘mRNA metabolic process’’ (ZFP36L2,
PTBP2, SFRS2IP, HNRNPC and RBM25; P-value=3.2E-3),
‘‘endoplasmic reticulum’’ (CTSZ, CNIH4, SLMAP, ATF6B, CNPY3
and ERGIC1; P-value=1.4E-2), as well as ‘‘chromatin organiza-
tion’’ (EPC1, HUWE1, MLL3 and MPHOSPH8; P-value=2.5E-2)
were significantly enriched. As an example, the expression profiles
of ERGIC1 (Endoplasmic Reticulum-Golgi Intermediate Com-
partment 1) were found highly variable between the series of
Figure 3. Illustrations of principle component analysis on the
blood sample gene expression profiles. Principle component
analysis was performed on gene expression profiles of 24 blood
samples. Samples were displayed in three-dimensional space consisting
of the Top-3 principal components which explain 55.4% of the variation
of the whole dataset. Colours indicate blood samples collected from the
same volunteers. Circles represent females and crosses represent male.
The distances between samples reflect their approximate degree of
transcriptional similarity. The individuals across three experimental
series were in close proximity to one another, whereas females and
males were separated.
doi:10.1371/journal.pone.0026905.g003
Table 2. Eigen-R
2 analysis for dissecting data variation,variable-associated gene identification and functional annotation
enrichment.
Variable
Proportion of
Variation Explained
by Variable (%)
N of Significant
Genes
(FDR,0.01) Top Enriched Functional Annotation Term*
Age 8.3 196 blood coagulation, blood vessel development, stem cell maintenance, inflammatory response
Gender 9.2 105 iron ion binding, kinase binding, defense response, negative regulation of signal transduction
BMI 5.3 122 natural killer cell mediated cytotoxicity, hematopoietic cell lineage, phosphatase activity
leukocyte 12.6 557 leukocyte activation, mitochondrial membrane organization, homeostasis of number of cells,
T cell receptor signaling pathway, immune response, cell activation, hemopoiesis, regulation
of apoptosis
lymphocyte% 15.3 1146
monocyte% 7.8 50
neutrophil% 16.4 1560
erythrocyte 8.6 299 negative regulation of apoptosis, iron ion binding, oxidation reduction, erythrocyte
differentiation
hemoglobin 3.6 60
reticulocyte% 3.7 7
platelet 4.3 24 immune response, nucleotide binding,
RIN value 2.1 28 mRNA metabolic process, endoplasmic reticulum, chromatin organization
All the gene lists as well as the corresponding functional annotation enriched terms obtained via DAVID were provided in the Table S3.
doi:10.1371/journal.pone.0026905.t002
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intensity of ERGIC1 dropped from 615 to 394 between Series_1
and Series_3, indicating the notable influence of sample RNA
quality on the individual gene expression profiles. Recently, the
technology advances such as RNA 6000 Nano Chips and Agilent
2100 Bioanalyzer had made it possible to access the samples’ RNA
quality beforehand. In case the quality of RNA was not satisfied,
one would simply discard it. However, our results showed that this
may not solve all the problems. Given the blood samples drawn
from the same donors and high quality RNAs in Series_1 and
Series_2 with the RIN values between 7.3 and 9.2, the expression
intensity of ERGIC1 were significantly different (P-value=0.002).
Hence, it could be also important to consider the distribution of
RIN variable and make it equally distributed between the
comparison groups.
Variation Associated with Age
The aging effect might contribute to 8.3% of the total variation
in blood gene expression profiles. A list of 196 genes was identified
to be significantly associated with the age variable. Interestingly,
several biological processes including ‘‘blood coagulation’’
(CD40LG, CD59, TFPI, SERPING1 and PF4; P-value=0.02),
‘‘blood vessel development’’ (CEACAM1, EPAS1, IL8 and TCF7L2;
P-value=0.45), ‘‘stem cell maintenance’’ (RIF1, TCL1A and
TCF7L2; P-value=0.03) and ‘‘inflammatory response’’ (C3AR1,
TNFSF4, IL8, CD40LG, HRH4, RIPK2, SERPING1, IDO1 and
CXCL10; P-value=0.02) were significantly enriched. Given the
fact that the blood vessel walls become thicker and tougher during
the aging process, it was not unexpected that the angiogenesis-
related genes were appeared in the list. On the other hand, the
blood itself also changes with age in different aspects. The amount
of bone marrow decreases with age, causing a decline in the
formation of new blood cells. Therefore, recovery from bleeding
episodes will be slowed. Age-related decline also occurs in white
blood cells. Most of the white blood cells stay at the same levels,
but certain white blood cells important to immunity (e.g.
lymphocytes) decrease in their number and ability to resist
inflammatory and infection.
We performed PCA and Eigen-R
2 analysis using the indepen-
dent Karlovich et al. dataset. The age variable was found to be
associated with 2.3% of the total variation. This value was in
accordant with what had been reported by Karlovich et al.,
however, somewhat lower compared to our result. We noticed
some differences between two studies that might contribute to the
discordance. The age range was smaller in our study (22–35 yrs)
compared to the Karlovich et al. study (23–64 yrs). Actually, 14 out
of 20 volunteers from Karlovich et al. dataset were above the
35 yrs old. Hence, it was not unexpected that our result could not
be fully retrieved from those samples. Furthermore, Karlovich et al.
explained that the broad age range in their study might have
prevented the detection of the aging effect in blood [10]. Although
similar observations had been reported previously [7,11], the aging
effect in blood transcriptome needs to be further specified with
more samples and a broad range of ages.
Variation Associated with Gender
The gender effect was found to be associated with 9.2% of the
total variation in blood gene expression data. A total of 105
gender-associated genes were identified at FDR ,0.01. It was
intriguing that the Top-10 gender-associated genes were located
on either the X or Y chromosomes (XIST, RPS4Y1, EIF1AY,
KDM5D, DDX3Y, CYorf15A, CYorf15B, USP9Y, UTY and PRKY).
The ectopic expression patterns of gene XIST (X Inactive Specific
Transcript) was observed showing an average intensity of 3,000 in
females and almost no expression in males. On the contrary, the Y
chromosome linked gene RPS4Y1 (Ribosomal Protein S4, Y-linked
1) was highly expressed in males with an average intensity of 1,800
but nearly no expression in females (Figure S1). In the Karlovich et
al. dataset, gender effect was associated with 9.7% of the total
variation, which was very similar to what was found in our dataset.
Furthermore, the specific patterns of XIST and RPS4Y1 were also
retrieved. The ratio of XIST to RPS4Y1 showed significantly
higher in females compared to males (P-value=1.6E-7), which
might represent a useful gender-associated biomarker for the blood
gene expression analyses in the future.
Variation Associated with BMI
Given the distinct distribution of BMI between men and
women, we included the gender variable to the Eigen-R
2 linear
regression model for the estimation of variation. The BMI variable
was found to be associated with 5.3% of the total variation. A total
of 122 BMI-associated genes were identified at FDR ,0.01. Of
these genes, a cluster of 9 genes known to be related to ‘‘natural
killer cell mediated cytotoxicity’’ were enriched (TNFRSF10A,
PRF1, KIR2DL5A, KIR2DS1, GZMB, KIR2DL1, KIR2DL3,
SH2D1B and KIR3DL1; P-value=8.2E-6). Other genes involving
in the ‘‘hematopoietic cell lineage’’ (CD38, CD8B, IL7 and CD5; P-
value=0.03) and ‘‘phosphatase activity’’ (ALPL, PTPRN2,
INPP4B, PSPH and NT5E; P-value=0.05) were also enriched in
the list.
Variation Associated with White Blood Cells
It was noteworthy that the white blood cell measures
(‘‘Leukocytes’’, ‘‘Lymphocyte %’’, ‘‘Monocyte %’’ and ‘‘Neutro-
phil %’’) were associated with 7.8% to 16.4% of the total variation.
Previously, white blood cells had been described as the most
transcriptionally active of all cell types in blood and might present
the most sensitive gene expression profiles in response to biological
Figure 4. ERGIC1 gene expression profiles across the series of
arrays. In x-axis, the samples were arranged in accordance with the
array Series 1–3 from the left to the right. Colours represent blood
samples collected from the same volunteers. The y-axis indicates the
gene expression signal intensity.
doi:10.1371/journal.pone.0026905.g004
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and Eigen-R
2 method, our result demonstrated that the heteroge-
neity of white blood cell constituents indeed contributed to the
most significant portion of the overall data variation. Via the gene-
wise linear analysis at FDR,0.01, we identified 50, 557, 1146 and
1560 genes associated with ‘‘Monocyte %’’, ‘‘Leukocytes’’,
‘‘Lymphocyte %’’ and ‘‘Neutrophil %’’, respectively. The white
blood cell counts had been shown highly correlated, hence we
combined the four gene sets together and resulted in a list of 1893
unique genes. As expected, numerous specific (e.g. ‘‘leukocyte
activation’’, P-value=2.7E-7; ‘‘mitochondrial membrane organi-
zation’’, P-value=2.7E-5; ‘‘homeostasis of number of cells’’, P-
value=8.1E-5; and ‘‘T cell receptor signalling pathway’’, P-
value=1.1E-2) as well as more general biological processes (e.g.
‘‘immune response’’, P-value=4.2E-10; ‘‘cell activation’’, P-
value=2.8E-8; ‘‘hemopoiesis’’, P-value=2.2E-5; and ‘‘regulation
of apoptosis’’, P-value=1.8E-4) were significantly enriched among
the list of leukocytes-associated genes. Hierarchical clustering of
the leukocytes-associated genes resulted in perfect clustering of
individual samples, demonstrating the predominating effect of
individual heterogeneities of leukocyte subsets on the blood gene
expression profiles (Figure 5).
Variation Associated with Red Blood Cells
Given the different physiological conditions between men and
women, the red blood cell counts were correlated with gender.
Hence, we included the gender variable into the Eigen-R
2 linear
regression model for the estimation of variation. The red blood
measures (‘‘reticulocyte%’’, ‘‘erythrocyte’’ and ‘‘hemoglobin’’) were
found to be associated with 3.6% to 8.6% of the total variation. A
total of 7, 60 and 299 genes were identified to be associated with
‘‘reticulocyte%’’, ‘‘erythrocyte’’ and ‘‘hemoglobin’’, respectively.
The three lists were combined and resulted in a set of 306 unique
genes. Interestingly, multiple relevant biological processes, such as:
‘‘negative regulation of apoptosis’’ (HTATIP2, GNRH1, SOCS3,
CLU, SNCA, PF4, PIM3, BCL2L1, STRADB, CSDA, MIF, PROK2,
Figure 5. Hierarchical clustering of leukocytes-associated genes across samples exhibiting significant inter-individual differences.
The expression profiles of 1893 leukocytes-associated genes across 24 samples were used for unsupervised hierarchical clustering. On the heat map,
each row represents one gene and each column represents one patient. Red colour indicates gene over-expressed and green colour indicates gene
low-expressed. Colours of bars associated with clustering of the columns designate samples from different donors. The leukocytes-associated genes
perfectly cluster individual samples, suggesting the predominating effect of individual heterogeneities of leukocyte subsets on the blood gene
expression profiles.
doi:10.1371/journal.pone.0026905.g005
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and F2R; P-value=4.1E-7), ‘‘iron ion binding’’ (STEAP4, UTY,
SNCA, EIF2AK1, CYP27A1, PGRMC1, HEBP1, HBZ, NDUFS8,
MPO, SLC25A37, HBQ1, KDM6B and KDM5D; P-value=1.0E-3),
‘‘oxidation reduction’’ (ACOX1, STEAP4, HTATIP2, DHRS13,
UTY, SNCA, GMPR, SLC25A12, ADI1, AKR1C3, SNAI3, CYP27A1,
PRDX6, BLVRB, NDUFS8, MPO, SMOX, ERO1L, KDM6B, NQO2
and KDM5D; P-value=4.5E-3), as well as ‘‘erythrocyte differenti-
ation’’ (TAL1, HBZ, BCL6 and KLF1; P-value=3.0E-2) were
significantly enriched.
Variation Associated with Platelets
Human blood platelets play critical roles in normal hemostatic
processes and pathologic conditions such as inflammation,
thrombosis, vascular remodelling, and wound repair. Although
platelets are anucleate and lack nuclear DNA, they retain
megakaryocyte-derived mRNAs [39]. Platelets contain rough
endoplasmic reticulum and polyribosomes, and thereby they
maintain the ability for protein biosynthesis from cytoplasmic
mRNA [40]. Quiescent platelets generally display minimal
translational activity, but newly formed platelets synthesize various
a-granule and membrane glycoproteins [41]. In our dataset, the
platelets variable was associated with 4.3% of the total variation.
The gene-wise linear analysis identified 24 platelet-associated
genes. Several genes involved in ‘‘immune response’’ (DDX58,
OAS3, RSAD2, IFI44L, OAS1, TREML1 and IFI6; P-value=3.6E-
5) as well as ‘‘nucleotide binding’’ (OAS1, OAS3, DDX6, DDX58,
NUAK1, CMPK2 and RNF213; P-value=5.6E-3) were significantly
enriched. Moreover, it was intriguing that PEAR1 (platelet
endothelial aggregation receptor 1) and GP3A (platelet glycopro-
tein III) were also found significantly associated, but with slightly
higher FDRs at 0.02 and 0.03, respectively.
Validation of the Microarray Data by Real-time PCR
Real-time PCR is generally considered the "gold-standard"
assay for measuring gene expression and is often used to confirm
findings from microarray data. A total of five genes (C3AR1, XIST,
LCK, OAS1 and IFIT1), which associated with age, gender and
blood cell counts in microarray data, were selected for real-time
PCR validation. The gene expression profiles determined by
microarray and real-time PCR were found to be highly correlated
(Table 3). Meanwhile, the real-time PCR based gene expression
profiles were also significantly associated with the age, gender,
lymphocyte%, reticulocyte% and platelet variables.
Discussion
In the study described here, we intended to characterize the
major sources of variation in the gene expression of human blood.
We used the PCA and Eigen-R
2 method to dissect the overall
variability of gene expression data and associate the major sources
of variation with the predefined biological and technological
factors. The results indicated that the predominating sources of the
variation could be traced to the individual heterogeneity of the
relative proportions of various blood cell types (leukocyte subsets
and erythrocytes). The physiological factors (age, gender and BMI)
were found to be associated with a significant proportion of
variation in blood gene expression profiles. We further used a large
independent dataset to perform the in silico validation. By applying
the same statistical analyse, the similar gender effect as well as
lessened aging effect was verified in the Karlovich et al. dataset.
Through the specific design, we investigated the blood gene
expression profiles from the same donors but with different levels
of RNA quality. Although the proportion of variation associated to
the RIN variable was mild, the significant impact of RNA quality
on the expression of individual genes was observed.
Remarkably, the individual heterogeneities of blood cell constit-
uents representthemostsignificant portion oftheoverallvariation in
blood gene expression. As a major defense and transport system, the
blood interacts with virtually every organ and tissue in the human
body, and thereby the gene expression responses of circulating white
blood cells can potentially provide early warning of any abnormal-
itiestheydiscover.Fromthispointofview,ourresultslendsupportto
the clinical use of blood transcriptomic biomarkers for exposure,
disease progression, diagnosis or prognosis. Given the significant
effect of the relative proportions of different blood cell types, it is
highly recommended to perform the CBC tests simultaneously and
integrated the blood cell counts into the blood transcriptome study.
For the donors with the blood cell counts falling outside normal
ranges, they should be excluded. In some cases the size effects of
biological or environmental factors are mite, the differences of gene
expression profiles between comparison groups can be whelmed by
the unconcerned individual heterogeneity and resulting in no
differentially expressed genes was found. Then, it is possible to
deconvolute blood gene expression profiles ‘‘in silico’’ if the measures
of blood cell counts are available. This type of analysis can help to
deduce cellular composition or cell-specific levels of gene expression
using statistical methodologies [42-44]. Ultimately, increasing the
samplesizeofcomparisongroupswheneverpossibleisalwayshelpful
to neutralize the unconcerned individual heterogeneity. In the study
design, physiological factors (age, gender and BMI) need to be well
controlled and have them equally distributed between the
comparison groups. The RNA quality of blood samples should be
accessed before geneexpression profiling. In casethe qualityofRNA
not fit the predefined criteria, samples should be removed. It is also
important to pay an attention to the global distribution of sample
quality and make it well balanced between the comparison groups.
Table 3. Validation of microarray data by real-time PCR.
Gene Associated variable Correlations with variable Correlations with microarray data
r P-value r P-value
C3AR1 age 0.82 8.4 E-7 0.95 2.0 E-6
XIST gender 0.87 4.2 E-8 0.75 2.0 E-5
LCK lymphocyte% 0.6 0.002 0.73 7.2 E-5
OAS1 reticulocyte% 20.65 0.001 0.87 2.5 E-6
IFIT1 platelet 20.77 1.1 E-5 0.94 2.2 E-6
doi:10.1371/journal.pone.0026905.t003
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PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26905Finally, our study extends the limited information base currently
available for the baseline variation of blood gene expression
profiling in Chinese population. The clinical and transcriptomic
data described in the study have been made freely available and
should represent a useful resource for the design of future studies.
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Figure S1 The ectopic expression patterns of XIST and
RPS4Y1 in men and women. In x-axis, the samples were
arranged in accordance with the array Series 1–3 from the left to
the right. Black and red dots represent blood samples collected
from men and women, respectively. The y-axis indicates the gene
expression signal intensity.
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